In April 2025, $UnitedHealth (UNH.US)$ (UNH) dropped 22% in a single day, marking the largest drop since 1998, with a Market Cap evaporating by 120 billion USD. The trigger was the first quarter Earnings Reports falling short of expectations, coupled with significant downward revisions to the annual EPS and operational guidance, leading to panic selling among investors. For Futubull investors in US stocks, this is not only a stock correction, but also a reassessment of the potential risks in the entire Medicare Advantage insurance market.
UnitedHealth's Q1 Earnings Reports show that the adjusted earnings per share (EPS) was $7.20, lower than the market expectation of $7.29; revenues were $109.6 billion, also below the estimated $111.6 billion. The most critical issue is the company's forecast for the 2025 full-year EPS, which has been revised down to $26–26.5 (originally projected at $29.5–30), mainly due to a significant increase in usage rates of medical services in the Medicare Advantage business, resulting in a substantial increase in medical cost pressures, severely eroding the gross margin structure.
As the largest healthcare insurance company in the USA, UNH's Medicare Advantage business has long been a main driver of growth. However, since 2025, medical inflation and rising demand for visits indicate that this market has...

$Berkshire Hathaway-B (BRK.B.US)$is about to release its Q1 2025 earnings. According to Zacks data, analysts expect the earnings per share (EPS) to be $4.81, which is a 7.32% decrease from the same period last year. The revenue is projected to be $92.21 billion, showing a 2.6% increase YoY. The average target price set by analysts is $557, while the current share price is $534.57. Based on the analysts' forecasts, this implies...